Thus, in this study, we aimed to evaluate LBP levels in relation to the presence of obesity and to investigate the association between circulating LBP and key metabolic disease parameters, including NAFLD, adipose tissue inflammation, and the presence of T2DM. The gene discussed is LBP; the disease is metabolic dysfunction-associated steatotic liver disease.